United States of America v. Healthcare Associates of Texas LLC

District Court, N.D. Texas·Decided May 5, 2023·No. 3:19-cv-02486·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF TEXAS DALLAS DIVISION

UNITED STATES OF AMERICA, ex § rel. CHERYL TAYLOR, § § Plaintiff, § § v. § Civil Action No. 3:19-CV-2486-N § HEALTHCARE ASSOCIATES § OF TEXAS, LLC, et al., § § Defendants. §

MEMORANDUM OPINION AND ORDER This order addresses Defendants’1 motion to strike and to dismiss [112]. The Court concludes that Relator Cheryl Taylor’s Second Amended Complaint2 (“2AC”) adequately states a claim for relief under the False Claims Act and denies the motion. I. ORIGINS OF THE DISPUTE Taylor alleges that she observed HCAT3 and its agents, the individual defendants, employ fraudulent Medicare billing practices. HCAT was founded and managed by Defendants Powell, Deems, Gaman, Feehery, and nondefendant Dr. Maria Baird (the “Founding Physicians”). 2AC ¶ 75. Taylor first worked for HCAT as an outside consultant. Id. ¶ 76. She audited HCAT’s healthcare billing practices in late 2017 and

1 The Second Amended Complaint (“2AC”) names Healthcare Associates of Texas, LLC, Healthcare Associates of Irving, LLP, David Harbour, Jeff Vines, Kristian Daniels, Dr. Charles L. Powell, Dr. David Deems, Dr. Walter Gaman, and Dr. Terrence Feehery. 2 The 2AC is redacted and docketed at [89] and available in full under seal at [112-1]. 3 The parties refer to Healthcare Associates of Texas, LLC and Healthcare Associates of Irving, LLP (“HCA-Irving”) collectively as “HCAT.” See 2AC ¶¶ 74–76. provided a follow-up assessment in May 2018. Id. at ¶ 76. In August 2018, Taylor accepted full-time employment with HCAT as the executive responsible for its revenue cycle. Id. ¶ 77. Throughout her tenure at HCAT, Taylor’s duties included submitting

claims for reimbursement to Medicare, reviewing denied claims, and interviewing every billing and coding department employee. Id. ¶¶ 77–78. According to Taylor, numerous HCAT policies required billing staff to submit claims for greater reimbursement than Medicare regulations allowed. Allegedly: 1. HCAT submitted claims with coding errors and without complete medical records to avoid delays in reimbursement. Id. ¶¶ 83–91.

2. HCAT submitted claims that named a treating physician who did not actually provide or supervise the claimed service in order to skirt credentialing requirements, secure higher reimbursement rates, and obtain reimbursement for nonreimbursable services. Id. ¶¶ 5, 7, 92– 161, 208, 212, 221–225.

3. HCAT also obtained reimbursement for nonreimbursable services by ordering unnecessary tests and services and manipulating billing codes and chart data. Id. ¶¶ 6, 162–214.

4. HCAT officials refused to return overpayments. Id. ¶¶ 215–220.

Taylor contends that she notified HCAT personnel, including compliance officer Kristian Daniels, CEO David Harbour, and then-CFO Jeff Vines, of the problematic practices. Id. ¶¶ 79, 91, 117–20, 160–61, 218. To her knowledge, HCAT did not correct its practices or disclose them to the government. Id. ¶ 79. HCAT terminated Taylor in January 2019. Id. ¶ 80. Taylor filed this qui tam action alleging several counts under the False Claims Act (“FCA”), 31 U.S.C. §§ 3729(a)(1). She subsequently sought leave to amend because the Government’s investigation and early discovery revealed that HCA-Irving should be named as a defendant. Rel.’s Unopp. Mot. Leave 1 [57]. Defendants did not oppose the filing of the First Amended Complaint (“1AC”) [58]. Id. at 6; see also Joint Stipulation

[62] (applying pending motion to dismiss briefing to amended complaint). But Defendants now argue that Taylor’s additional amendments impermissibly rely on material obtained in discovery, and they ask the Court to strike portions of the 2AC as well as dismiss it entirely for failure to state a claim. II. LEGAL STANDARDS Motion to Strike Under Federal Rule of Civil Procedure 12(f), the Court “may strike from a

pleading an insufficient defense or any redundant, immaterial, impertinent, or scandalous matter.” FED. R. CIV. P. 12(f). Granting a motion to strike is a drastic remedy that should be used sparingly. Augustus v. Bd. of Pub. Instruction, 306 F.2d 862, 868 (5th Cir. 1962) (citing Brown & Williamson Tobacco Corp. v. United States, 201 F.2d 819, 822 (6th Cir. 1953)). The Court should strike a matter as impertinent or immaterial only

when it has “no possible relation to the controversy.” Augustus, 306 F.2d at 868 (citing Brown & Williamson Tobacco Corp., 201 F.2d at 822). Beyond the scope of Rule 12(f), courts also retain inherent powers to “fashion an appropriate sanction for conduct which abuses the judicial process,” including striking material as impermissible. United States v. SouthEast Eye Specialists, PLLC, 570 F. Supp. 3d 561, 571 (M.D. Tenn. 2021)

(quoting Royce v. Michael R. Needle P.C., 950 F.3d 939, 953 (7th Cir. 2020)) (internal quotations omitted). Motion to Dismiss for Failure to State a Claim When addressing a motion to dismiss pursuant to Federal Rule of Civil Procedure 12(b)(6), a court must determine whether the plaintiff has asserted a legally sufficient

claim for relief. Blackburn v. City of Marshall, 42 F.3d 925, 931 (5th Cir. 1995). “When reviewing a motion to dismiss, a district court must consider the complaint in its entirety, as well as … documents incorporated into the complaint by reference, and matters of which a court may take judicial notice.” Funk v. Stryker Corp., 631 F.3d 777, 783 (5th Cir. 2011) (internal quotation marks omitted).

A viable complaint includes “enough facts to state a claim to relief that is plausible on its face.” Bell Atlantic Corp. v. Twombly, 550 U.S. 544, 570 (2007). A court generally accepts well-pleaded facts as true and construes the complaint in the light most favorable to the plaintiff. Gines v. D.R. Horton, Inc., 699 F.3d 812, 816 (5th Cir. 2012). The facts are “taken collectively” rather than “scrutinized in isolation.” Tellabs, Inc. v.

Makor Issues & Rights, Ltd., 551 U.S. 308, 322–23 (2007). But a plaintiff must provide “more than labels and conclusions, and a formulaic recitation of the elements of a cause of action will not do.” Twombly, 550 U.S. at 555 (internal citations omitted). “Factual allegations must be enough to raise a right to relief above the speculative level … on the assumption that all the allegations in the complaint are true.” Id. (internal citations omitted). A complaint is plausible if it “pleads factual content that allows the court to

draw the reasonable inference that the defendant is liable for the misconduct alleged.” Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009). Claims of misconduct are “merely conceivable and not plausible” if their supporting facts have a more obvious legal explanation. U.S. ex rel. Integra Med Analytics, L.L.C. v. Baylor Scott & White Health, 816 F. App’x 892, 897 (5th Cir. 2020) (unpub) (quoting Iqbal, 556 U.S. at 682).

Free access — add to your briefcase to read the full text and ask questions with AI

United States of America v. Healthcare Associates of Texas LLC, (N.D. Tex. 2023).

United States of America v. Healthcare Associates of Texas LLC (United States of America v. Healthcare Associates of Texas LLC) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Tuchman v. DSC Communications Corp.
14 F.3d 1061 (Fifth Circuit, 1994)
Williams v. WMX Technologies, Inc.
112 F.3d 175 (Fifth Circuit, 1997)
United States Ex Rel. Grubbs v. Kanneganti
565 F.3d 180 (Fifth Circuit, 2009)
Arista Records, LLC v. Doe 3
604 F.3d 110 (Second Circuit, 2010)
Tellabs, Inc. v. Makor Issues & Rights, Ltd.
551 U.S. 308 (Supreme Court, 2007)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Ronald Funk v. Stryker Corporation
631 F.3d 777 (Fifth Circuit, 2011)
Brown & Williamson Tobacco Corp. v. United States
201 F.2d 819 (Sixth Circuit, 1953)
Jimmy Blackburn v. Marshall City Of
42 F.3d 925 (Fifth Circuit, 1995)
United States v. Peter MacKby
261 F.3d 821 (Ninth Circuit, 2001)
Mike Gines v. D.R. Horton, Incorporated
699 F.3d 812 (Fifth Circuit, 2012)
US Ex Rel. Underwood v. Genentech, Inc.
720 F. Supp. 2d 671 (E.D. Pennsylvania, 2010)